As I prepare my presentation for the @mobiquityinc Wireless Innovation Council  in a couple of days, I’ve been thinking about the evolution of how our company went from Product-to-Methodology.

I’ve been asked to look at my discussion in terms of problem, methodology, outcomes and the lessons we’ve learned.

As Roni Zeiger once expressed, mhealth is a series of intersections. Over the years, we at MEMOTEXT have found that the primary challenge of adherence is centered squarely in the intersection of technology and the healthcare stakeholder – between patient, payer, pharma, pharmacy, pbm and/or provider.

To us, it is the intersection between how patients interact with their healthcare. From a human-computer perspective, it’s how people express themselves and how a computer or a device should communicate with an individual to help support them.  Secondly, it is how the allure of marketing  cross-pollinates with health in creating applications and interactions that are engaging and essentially “do not suck”. And finally, it is how we go about bringing together the intersections of technology, front-line healthcare stakeholders (continuum integration), and the bottom line?

The question then becomes, how do we blend legitimacy, validity and scientific rigour with commercialism and retain an ability to be “lean” and viable?

At MEMOTEXT we’re applying what we learn on an ongoing basis to bridge these intersections. We’re creating an engine and a replicable multidisciplinary (more intersections) methodology and a tool to help us solve or at least move the needle in the medication adherence/compliance equation. We’re also trying to replicate and systematize lessons learned to reduce the cost of an automated healthcare interaction. You can read all about our methodology here and the big problem of adherence here 

The intersections are endless and we hope to be there as an engine for growth in bringing these intersections closer together.

 

AMOS ADLER M.Sc.
FOUNDER & PRESIDENT

img35

Amos brings speech, mobile and social technologies together to create mobile (mHealth) and telehealth patient adherence programs. Since 2008, Amos has led the design and deployment of dozens of digital patient adherence and behavior change programs globally while advocating for evidence-based approaches to technology-based behavior change. With a background in user oriented design methodologies, user-requirements elicitation, finance and enterprise scale technology deployment, Amos focuses on solutions solving real-world business requirements with patient centered designs while understanding the challenges of change management in clinical settings.

Prior to founding MEMOTEXT, Amos held multiple technology and finance related positions within the Bell Canada Holdings family of companies as well as a background in social and private real estate development. Amos holds a M.Sc. in Analysis, Design and Management of Information Systems from The London School of Economics in London England, graduating with distinction was highlighted by his work within the launch of the world’s first independent exchange for international wholesale telecom capacity.

Amos speaks regularly at events such as: mHealth, Stanford Medicine X, Health Datapalooza, Genentech FutureMed2.0 and guest lectures at the Univ. of Toronto.